BG25091A3 - A method of obtaining 7-acylamide-3-fluorcephalosporic compounds - Google Patents

A method of obtaining 7-acylamide-3-fluorcephalosporic compounds

Info

Publication number
BG25091A3
BG25091A3 BG026510A BG2651074A BG25091A3 BG 25091 A3 BG25091 A3 BG 25091A3 BG 026510 A BG026510 A BG 026510A BG 2651074 A BG2651074 A BG 2651074A BG 25091 A3 BG25091 A3 BG 25091A3
Authority
BG
Bulgaria
Prior art keywords
fluorcephalosporic
acylamide
compounds
obtaining
fluorcephalosporic compounds
Prior art date
Application number
BG026510A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gary Koppel
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG25091A3 publication Critical patent/BG25091A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG026510A 1974-02-06 1974-04-25 A method of obtaining 7-acylamide-3-fluorcephalosporic compounds BG25091A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US439206A US3926978A (en) 1974-02-06 1974-02-06 Process for preparing 3-fluorocephalosporins

Publications (1)

Publication Number Publication Date
BG25091A3 true BG25091A3 (en) 1978-07-12

Family

ID=23743733

Family Applications (1)

Application Number Title Priority Date Filing Date
BG026510A BG25091A3 (en) 1974-02-06 1974-04-25 A method of obtaining 7-acylamide-3-fluorcephalosporic compounds

Country Status (32)

Country Link
US (1) US3926978A (es)
JP (1) JPS612678B2 (es)
AR (1) AR202209A1 (es)
AT (1) AT329181B (es)
BE (1) BE813169A (es)
BG (1) BG25091A3 (es)
BR (1) BR7404085A (es)
CA (1) CA1017741A (es)
CH (1) CH598263A5 (es)
DD (1) DD117465A5 (es)
DE (1) DE2417988A1 (es)
DK (1) DK119874A (es)
EG (1) EG11061A (es)
ES (1) ES427235A1 (es)
FI (1) FI99474A (es)
FR (1) FR2259826B1 (es)
GB (1) GB1462944A (es)
GT (1) GT197432532A (es)
HU (1) HU167748B (es)
IE (1) IE38980B1 (es)
IL (1) IL44361A (es)
IN (1) IN139927B (es)
MW (1) MW1074A1 (es)
NL (1) NL7403126A (es)
NO (1) NO741093L (es)
OA (1) OA04641A (es)
PH (1) PH12616A (es)
PL (1) PL90989B1 (es)
RO (1) RO63021A (es)
SE (1) SE411453B (es)
ZA (1) ZA741423B (es)
ZM (1) ZM5674A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208515A (en) * 1973-02-23 1980-06-17 Eli Lilly And Company 3-Halo cephalosporins
US4064343A (en) * 1974-04-01 1977-12-20 Eli Lilly And Company 3-Halo cephalosporins
US4260745A (en) * 1979-10-12 1981-04-07 Eli Lilly And Company 3-Halo cephalosporins
US4281116A (en) * 1979-10-12 1981-07-28 Eli Lilly And Company 3-Halo cephalosporins
US4252950A (en) * 1979-10-12 1981-02-24 Eli Lilly And Company 3-Halo cephalosporins
DE3851449T2 (de) * 1987-02-27 1995-03-16 Banyu Pharma Co Ltd Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
JPH0343723A (ja) * 1989-07-11 1991-02-25 Japan Servo Co Ltd 投影器
WO1993011132A1 (de) * 1991-12-06 1993-06-10 Ciba-Geigy Ag Verfahren zur herstellung des antibiotikums cefaclor
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830808A (en) * 1968-06-14 1974-08-20 Glaxo Lab Ltd Cephalosporins having a thioetherified methyl group at the 3-position
GB1377651A (en) * 1971-01-12 1974-12-18 Glaxo Lab Ltd Esters

Also Published As

Publication number Publication date
ES427235A1 (es) 1976-07-16
FI99474A (es) 1975-08-07
IL44361A0 (en) 1974-06-30
DK119874A (es) 1975-09-29
IE38980B1 (en) 1978-07-05
DE2417988A1 (de) 1975-08-07
CA1017741A (en) 1977-09-20
IN139927B (es) 1976-08-21
ATA312174A (de) 1975-07-15
FR2259826A1 (es) 1975-08-29
MW1074A1 (en) 1975-07-09
SE411453B (sv) 1979-12-27
SE7403307L (es) 1975-08-07
GB1462944A (en) 1977-01-26
JPS612678B2 (es) 1986-01-27
AU6640374A (en) 1975-09-11
JPS50108287A (es) 1975-08-26
US3926978A (en) 1975-12-16
AT329181B (de) 1976-04-26
OA04641A (fr) 1980-07-31
GT197432532A (es) 1975-09-25
ZA741423B (en) 1975-10-29
AR202209A1 (es) 1975-05-23
BR7404085A (pt) 1976-01-27
IL44361A (en) 1977-07-31
FR2259826B1 (es) 1977-06-24
IE38980L (en) 1975-08-06
PH12616A (en) 1979-07-05
RO63021A (fr) 1978-05-15
NL7403126A (nl) 1975-08-08
HU167748B (es) 1975-12-25
ZM5674A1 (en) 1977-04-21
EG11061A (en) 1976-11-30
NO741093L (es) 1975-09-01
BE813169A (fr) 1974-10-02
CH598263A5 (es) 1978-04-28
DD117465A5 (es) 1976-01-12
PL90989B1 (es) 1977-02-28

Similar Documents

Publication Publication Date Title
BG25094A3 (en) A method of obtaining substituted purines
JPS53101385A (en) Method of producing phenyllpyrimidine
CS188985B2 (en) Method of producing aryl-1-azolylmethanes
BG24950A3 (en) A method of obtaining 1,3,4-trisubstituted-4-arilpiperidines
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
BG24959A3 (en) A method of obtaining aminosacchars
BG25074A3 (en) A method of obtaining substituted perhaloalkylamidines
BG25082A3 (en) A method of obtaining 1-aroyl-2-arylamine-2-imidazole derivatives
BG25804A3 (en) A method of obtaining pseudotrisaccharides
BG24542A3 (en) Method of preparing carbonylaldiminomethanphosphonates
BG25797A3 (en) A method of obtaining azapurinoni
CS187318B2 (en) Method of producing acylureidocephalosporin compounds
ZA753873B (en) A method of preparing plaster
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
BG24807A3 (en) Method of obtaining pyridobenzodiazepinones
BG25070A3 (en) A method of obtaining alpha-6-deoxytetracyclines
BG25513A3 (en) A method of obtaining thiolcarbamates
BG25091A3 (en) A method of obtaining 7-acylamide-3-fluorcephalosporic compounds
CS188938B2 (en) Method of producing xanthene-9-spiro-4-piperidines
BG25518A3 (en) A method of obtaining xantain derivatives
BG25520A3 (en) A method of obtaining tetrasubstituted organo-stannic compounds
CS189635B2 (en) Method of producing bromderivatives of 4-imido-thioazetidin-2-one
BG25081A3 (en) A method of obtaining isohinolines
BG25080A3 (en) A method of obtaining of pyridincarboxamide sulphonylcarbamides
BG25226A3 (en) A method of obtaining condensed pyridine-4-(3h)-oni